Histogen Announces $5M Private Placement Priced At-The-Market Under Nasdaq Rules
Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and